Achilles Tendinitis in Runners 2026 | Podiatrist

Feature	Insertional Achilles Tendinopathy	Non-Insertional Achilles Tendinopathy
Location	At the Achilles-calcaneus insertion (within 2cm of insertion)	Mid-portion tendon, 2-6cm above insertion
Peak age / runner type	Masters runners (40+); higher BMI; tight gastrocnemius	Younger runners; high-volume training; sudden mileage increase
Associated finding	Haglund’s deformity (calcaneal prominence); calcaneal enthesophyte; retrocalcaneal bursitis	Intratendinous degeneration; neovascularization; mucoid change on MRI
Pain with heel raises	Pain at insertion; worse with end-range dorsiflexion (compresses insertion)	Pain at mid-tendon; improves slightly with activity warm-up
Eccentric exercises	Modified protocol only: eccentric on flat (NOT over step edge – increases insertional compression)	Standard Alfredson eccentric protocol: heel drops off step edge
Heel lift effect	Critical – heel lift reduces insertional compression; most important initial intervention	Helpful but less critical; reduces tendon load during healing
Zero/low-drop shoe risk	CONTRAINDICATED – increases insertional compression dramatically	Caution – increases tendon load; avoid during acute flare
Surgery (if refractory)	Haglund resection + calcification removal + tendon debridement; Haglund’s excision essential	Tendon debridement; stripping procedure; remove neovascularization

Treatment	Evidence Level	Best Indication	Success Rate	Timeline
Alfredson Eccentric Protocol (non-insertional)	Level I (multiple RCTs)	Non-insertional Achilles tendinopathy; duration >6 weeks	60-80% significant improvement	12-week protocol; 3 sets x 15 reps, twice daily
Heavy Slow Resistance (HSR) Training	Level I (non-inferior to eccentric)	Both insertional and non-insertional; better patient compliance than Alfredson	60-80%; equivalent to Alfredson at 12 months	12-week protocol; 3x/week; slower cadence than Alfredson
ESWT (Shockwave)	Level I for non-insertional; Level II for insertional	Chronic tendinopathy (>3 months) failed exercise therapy	65-80% improvement at 12 weeks	3-5 sessions weekly to monthly; durable effect at 12+ months
PRP Injection	Level II (conflicting evidence; recent large RCTs negative for non-insertional)	Partial tear with >50% thickness involvement; failed exercise + ESWT	55-75% (variable by study)	1-3 injections; ultrasound-guided; 4-6 weeks protection after
Corticosteroid Injection	CAUTION – Level I evidence of tendon weakening	Retrocalcaneal bursitis only (not into tendon); short-term symptom relief	60-70% short-term; NOT durable; rupture risk if repeated	Single injection max; avoid direct tendon injection
Surgical Debridement	Level III (observational)	Failed 6+ months of comprehensive conservative management	70-85% return to running post-surgery	3-6 months recovery; 6-9 months to full running fitness

Quick answer: Achilles Tendinitis Runners is a common foot/ankle topic that affects many patients. The 2026 evidence-based approach combines proper diagnosis, conservative-first treatment, and escalation only when needed. We treat this regularly at our Howell and Bloomfield Hills practices. Call (810) 206-1402.

https://www.youtube.com/watch?v=Y1sMEi7LNuA

Why Runners Develop Achilles Tendinitis

Achilles tendinitis — more accurately termed Achilles tendinopathy in contemporary sports medicine, as ‘itis’ (inflammation) is a misnomer for what is primarily a degenerative condition — is the most common overuse injury of the Achilles tendon in runners. Approximately 10% of recreational runners and up to 50% of elite runners experience Achilles tendinopathy at some point in their careers. The tendon must absorb 6–8 times body weight forces during running, and when cumulative loading exceeds the tendon’s adaptive capacity, collagen fiber disruption and degenerative changes begin.

The classic mechanism is a training error: sudden increases in weekly mileage, introduction of hill or speed work, or transition to a new shoe with significantly less heel drop. The gastrocnemius and soleus muscles — and the Achilles tendon they share — have limited capacity to adapt to sudden load increases. When loading increases faster than the tendon’s cellular repair mechanisms can respond, cumulative micro-damage outpaces repair, and tendinopathy develops.

Structural risk factors include tight calf muscles (reduced ankle dorsiflexion), overpronation, flat feet, and leg length discrepancy. Male runners are affected more commonly than female runners, and runners over 40 have significantly higher rates due to age-related reductions in tendon collagen turnover. Previous Achilles injury is the strongest predictor of future injury, making proper rehabilitation after the first episode essential for long-term running health.

Midportion vs. Insertional Achilles Tendinopathy

Achilles tendinopathy occurs at two distinct locations, each with different underlying pathology and treatment implications. Midportion tendinopathy — the most common type in runners — affects the central third of the tendon, approximately 2–6 cm above the heel bone insertion. This area has the poorest intrinsic blood supply in the tendon and the highest tensile loading during running, making it uniquely vulnerable to degenerative change. The tendon may develop a palpable nodule at this location representing focal collagen disruption.

Insertional Achilles tendinopathy affects the bone-tendon junction at the heel bone, sometimes accompanied by a Haglund’s deformity (a bony prominence at the posterosuperior calcaneus that compresses the tendon) and retrocalcaneal bursitis. This variant is more common in older runners and responds differently to treatment — most notably, the heel drop eccentric exercise program highly effective for midportion disease can worsen insertional tendinopathy by increasing compression at the calcaneotendonal junction.

The clinical distinction is made by palpation: midportion tendinopathy is tender in the central tendon body, while insertional tendinopathy is tender at the heel bone attachment. Treatment protocols should be selected based on which variant is present, as using the wrong protocol produces poor results and potentially worsens the condition.

Evidence-Based Treatment for Achilles Tendinitis in Runners

The Alfredson eccentric heel drop protocol — performing 3 sets of 15 repetitions of eccentric heel drops (raising on two feet, lowering slowly on one) on a step, twice daily for 12 weeks — remains one of the most evidence-supported treatments for midportion Achilles tendinopathy. The eccentric loading stimulates collagen synthesis and remodeling within the tendon, progressively improving its mechanical properties. Full adherence to the protocol produces good-to-excellent results in 70–80% of patients.

Heavy slow resistance training — performing slow, controlled heel raises with significant added load — has emerged as an equally effective alternative to eccentric training that many patients find more manageable. Combined eccentric-concentric protocols performed 3x per week also produce excellent outcomes. The common thread is that progressive mechanical loading of the tendon through a specific resistance program is the most effective conservative treatment, far superior to rest, stretching, or anti-inflammatory medications alone.

For runners who fail conservative loading programs after 3–6 months, advanced interventions include PRP injection (which delivers concentrated growth factors directly to the degenerated tendon tissue), shockwave therapy (which stimulates neovascularization and healing response in the degenerative tissue), and ultrasound-guided percutaneous tendon scraping. Surgery is rarely indicated but available for truly refractory cases. Dr. Tom Biernacki provides comprehensive Achilles tendinopathy management including loading program guidance, imaging, and advanced injection procedures when conservative rehabilitation is insufficient.

Dr. Tom's Product Recommendations

In-Office Treatment at Balance Foot & Ankle

If home treatment isn’t providing relief for your Achilles tendon conditions, our podiatry team at Balance Foot & Ankle can help with same-day evaluations and advanced in-office care.